Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance for Ovarian Cancer Research

By HospiMedica staff writers
Posted on 14 Sep 2005
A research collaboration to accelerate the development of new diagnostic tools to identify ovarian cancer has been announced by Ciphergen Biosystems, Inc. More...
(Fremont, CA, USA) and the University of Kentucky (Louisville, USA). Under the terms of the agreement, Ciphergen will have exclusive rights to license discoveries made that are part of the university's own ongoing research in ovarian cancer.

Ciphergen is to provide researchers at the University of Kentucky with its suite of proteomic solutions: Deep Proteome, Pattern Track Process, and ProteinChip. These are designed for biomarker discovery and the development of assays to analyze clinical samples collected by University of Kentucky Healthcare. The researchers will analyze patients' tumor cyst fluid and blood, looking for specific proteins to differentiate malignant from benign ovarian conditions.

"Medical management is entirely different for an ovarian tumor of low or no malignant potential versus one that is overtly malignant,” explained Dr. Fred Ueland, assistant professor of obstetrics and gynecology at the university. "With Ciphergen, we hope to accelerate the development of a new diagnostic approach to ovarian cancer by combining their biomarker discover and diagnostic process with our clinical experience.”

Gail Page, president and CEO of Ciphergen, observed, "The University of Kentucky is a major referral center for the treatment of gynecological malignancies. We are very pleased to be collaborating in our mutual goal to develop novel diagnostics in the field of ovarian cancer.”




Related Links:
Ciphergen
Univ. of Kentucky

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.